Aging of the eyelid area involves two distinct facial anatomy zones: the upper eyelid and the lower eyelid. Both undergo volume loss through different mechanisms, and filler treatment requires separate technical knowledge for each zone. In this article we cover everything from supraorbital hollowing treatment to the lid-cheek junction filler approach, vascular safety protocols, and the boundary between filler and surgery. At Virtuana Clinic, eyelid filler indications for patients from the Izmit and Kocaeli region are carefully assessed according to individual anatomy.
Aging Anatomy of the Upper Eyelid
Upper eyelid aging is related to volume loss in the fat pads. The upper eyelid, which appears full and round in youth, acquires a "hollow" and sunken look over time. The underlying cause is atrophy of the orbital fat pad and bone remodeling.
Supraorbital hollowing makes the eye appear "tired, sad, or old." The deep hollow between the brow and the upper lid affects the overall perception of the entire face. This anatomical change may occur together with dermatochalasis (excess skin) or independently.
Upper Eyelid Supraorbital Filler Technique
Filler treatment of the supraorbital region is one of the most technically demanding injection sites on the face. Key principles:
- Limiting the volume: A total of 0.1–0.3 ml of filler is sufficient for most upper eyelid cases. Excessive filler leads to brow ptosis and a sensation of eyelid heaviness.
- Supraperiosteal technique: The filler is deposited just above the orbital rim, on the periosteum (close to the bone surface). More superficial injection increases the risk of vascular injury.
- Product selection: Highly cohesive, low-hygroscopic, non-firm (soft lift) HA filler products are preferred. Firm products can cause edema and nodularity.
- Cannula use: A blunt-tipped microcannula (25–27 G) is preferred over a needle in the upper eyelid region; this minimizes vascular injury risk.
Lower Eyelid Filler: Focusing on the Lid-Cheek Junction
Lower eyelid aging has two components: tear trough hollowing and lid-cheek junction deformity. This article focuses on the lid-cheek junction because the curvature and depression at the junction of the tear trough and the cheek requires a distinct technique.
For lid-cheek junction filler:
- Denser filler in the mid-cheek (submalar area) softens the lid-cheek transition
- Instead of direct injection into the lower eyelid, the filler's volume effect on the cheek can be allowed to reflect onto the lid (indirect lift technique)
- Superficial injection should be avoided to prevent the Tyndall effect
Vascular Safety Map: Supraorbital and Supratrochlear Arteries
The most critical safety issue in periorbital filler procedures is vascular anatomy. Two important vessels in this region:
| Vessel | Location | Risk | Precaution |
|---|---|---|---|
| Supraorbital artery | Supraorbital foramen — at the level of mid-brow | Globe ischemia and blindness with incorrect injection | Stay away from the foramen; supraperiosteal depot |
| Supratrochlear artery | Above the medial canthus, approximately 1.7 cm lateral | Retinal vascular occlusion | Aspiration; blunt cannula preferred |
| Angular artery (medial) | Runs along the medial canthus | Orbital embolism | Extreme caution near medial region |
| Infraorbital artery | Below the orbital rim, infraorbital foramen | Lower eyelid and mid-face ischemia | Supraperiosteal injection; stay away from foramen |
Why Is an Aspiration Protocol Mandatory?
The aspiration protocol in eyelid filler procedures is an unquestionable safety standard. While a positive aspiration does not conclusively confirm that the needle tip is intravascular (only approximately 1% does), a negative result reduces risk and is one safety step among several. More important protocol steps:
- Small volumes (0.05 ml) and slow injection speed — sudden pressure increases occlusion risk
- Continuous observation of the patient's face — pain, pallor, or visual change is a warning sign
- Hyaluronidase (hyaluronidase) must always be on hand
Retinal Embolism: Emergency Protocol
The most severe complication following filler is visual loss due to vascular occlusion. Steps to be taken immediately upon suspicion:
- Stop the procedure immediately
- Attempt retrograde aspiration if possible
- Inject high-dose hyaluronidase (150–300 IU) into the affected area and periorbital region
- Refer the patient urgently to an ophthalmology clinic (retinal compression treatment — ocular massage, IOP-lowering medications, hyperbaric oxygen)
- Time is critical: a 90-minute window for vision salvage
Although this scenario is extremely rare, all filler practitioners at Virtuana Clinic are trained in this protocol and a hyaluronidase stock is kept ready at the clinic.
Upper Eyelid Filler vs. Surgery?
Determining the boundary between upper eyelid filler and blepharoplasty (eyelid cosmetic surgery) ensures proper guidance for the patient:
| Condition | Is Filler Appropriate? | Notes |
|---|---|---|
| Mild supraorbital hollowing, no excess skin | Yes | Ideal filler candidate |
| Moderate supraorbital hollowing + minimal excess skin | Partial — combined approach | Filler provides partial correction; patient should be informed |
| Significant dermatochalasis (skin laxity) | No — surgery recommended | Filler cannot lift excess skin; result will not be visible |
| Advanced ptosis (lid drooping) | No — surgery essential | Levator muscle repair is required |
Filler Longevity and Follow-Up
Hyaluronic acid filler products used in the eyelid region typically last 9–14 months. This duration varies depending on the dynamic movement of the eyelid and the product used. The product may persist somewhat longer in the upper eyelid, whereas metabolism may be faster in the lower eyelid (tear trough) region.
Before a top-up session, a clinical evaluation is essential: how much of the previous filler remains, and whether there is any evidence of Tyndall effect or migration.
Virtuana Clinic Eyelid Filler Assessment
For patients considering eyelid filler in the Izmit and Kocaeli region, our clinic conducts the following assessment: photographic analysis (frontal and angled views), brow position and lid relationship, orbital fat pad evaluation, measurement of excess skin, and overall facial aging balance. Based on this assessment, a plan involving filler, Botox, surgery, or a combination is determined.
Frequently Asked Questions
I want filler on my eyelid — which filler is used? Low-viscosity, soft-consistency hyaluronic acid filler products (e.g., low-cohesion formulations) are preferred for this region. Firm, high-lifting products are not suitable for the eyelid.
Is it painful? Discomfort can be minimised with a combination of topical anesthetic cream and lidocaine-containing filler products.
How long does swelling last after the procedure? The eyelid region is one of the areas most prone to swelling on the body. Swelling may become more pronounced in the first 48–72 hours; with cold compresses and head elevation, it largely resolves within 5–7 days.
This article is for informational purposes only. Please consult a qualified physician for treatment decisions.